BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2244252)

  • 1. [Low dose methotrexate therapy in rheumatoid arthritis].
    Shinozawa T; Akama H; Matsushita Y; Tanaka H; Yamada H; Suzuki Y; Ichikawa Y; Homma M
    Ryumachi; 1990 Jun; 30(3):172-80. PubMed ID: 2244252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
    Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
    Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose methotrexate in rheumatoid arthritis.
    Weinblatt ME; Coblyn JS; Fox DA; Fraser PA; Holdsworth DE; Glass DN; Trentham DE
    N Engl J Med; 1985 Mar; 312(13):818-22. PubMed ID: 3883172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.
    Gabriel S; Creagan E; O'Fallon WM; Jaquith J; Bunch T
    J Rheumatol; 1990 Apr; 17(4):460-5. PubMed ID: 2348423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Small R; Wolfe F
    J Rheumatol; 1991 Mar; 18(3):334-8. PubMed ID: 1856803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    Mielants H; Veys EM; Van der Straeten C; Ackerman C; Goemaere S
    J Rheumatol; 1991 Jul; 18(7):978-83. PubMed ID: 1920332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
    Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS
    J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of rheumatoid arthritis with low dose pulse methotrexate--comparative study with other disease modifying antirheumatic drugs].
    Murayama T; Ubukata A; Nakazaki S
    Ryumachi; 1992 Feb; 32(1):3-11. PubMed ID: 1604414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost].
    Ka MM; Diallo S; Ka EF; Diop BM; Pouye A; Mbengue M; Leye A; Diouf B; Diop TM
    Sante; 2000; 10(1):65-8. PubMed ID: 10827366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.
    Sany J; Anaya JM; Lussiez V; Couret M; Combe B; Daures JP
    J Rheumatol; 1991 Sep; 18(9):1323-7. PubMed ID: 1757932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
    Weinblatt ME; Maier AL; Fraser PA; Coblyn JS
    J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methotrexate (MTX) in the treatment of rheumatoid arthritis].
    Ge MZ; Zhang XS; Xieng W
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):81-3, 126. PubMed ID: 2737039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.